We are live on ! Find out more
WA

WealthTrust Axiom Portfolio holdings

AUM $406M
1-Year Est. Return 40.44%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+40.44%
3 Year Est. Return
+100.92%
5 Year Est. Return
+149.01%
10 Year Est. Return
+434.05%
AUM
$320M
AUM Growth
+$7.29M
Cap. Flow
-$2.64M
Cap. Flow %
-0.82%
Top 10 Hldgs %
28.91%
Holding
284
New
14
Increased
76
Reduced
75
Closed
14

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$1.47M
2
BUD icon
AB InBev
BUD
+$1.03M
3
CEG icon
Constellation Energy
CEG
+$763K
4
COHR icon
Coherent
COHR
+$721K
5
SHEL icon
Shell
SHEL
+$712K

Sector Composition

Rank Sector Weight
1 Technology 20.09%
2 Healthcare 13.4%
3 Industrials 12.89%
4 Energy 11.55%
5 Communication Services 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMT
251
Aberdeen Multi-Market Income Fund
MMT
$236M
$61K 0.02%
11,500
BGY icon
252
BlackRock Enhanced International Dividend Trust
BGY
$524M
$60K 0.02%
10,500
BRW
253
Saba Capital Income & Opportunities Fund
BRW
$336M
$45K 0.01%
5,060
BGC icon
254
BGC Group
BGC
$5.45B
$44K 0.01%
10,000
AUD
255
DELISTED
Audacy, Inc.
AUD
$43K 0.01%
15,158
MNOV icon
256
MediciNova
MNOV
$65.5M
$33K 0.01%
12,500
GNSS icon
257
Genasys
GNSS
$76.1M
$31K 0.01%
11,600
BNTC icon
258
Benitec Biopharma
BNTC
$402M
$30K 0.01%
762
HYMCL
259
DELISTED
Hycroft Mining Holding Corp Warrants
HYMCL
$23K 0.01%
33,500
RGLS
260
DELISTED
Regulus Therapeutics
RGLS
$20K 0.01%
6,800
APTO
261
DELISTED
Aptose Biosciences, Inc.
APTO
$20K 0.01%
33
CARM
262
DELISTED
Carisma Therapeutics
CARM
$19K 0.01%
1,588
GNCA
263
DELISTED
Genocea Biosciences, Inc.
GNCA
$18K 0.01%
15,000
GERN icon
264
Geron
GERN
$828M
$13K ﹤0.01%
10,000
BIOR
265
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$11K ﹤0.01%
40
MRKR icon
266
Marker Therapeutics
MRKR
$18.8M
$9K ﹤0.01%
2,270
KRBP
267
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$8K ﹤0.01%
333
ABEO icon
268
Abeona Therapeutics
ABEO
$366M
$5K ﹤0.01%
760
PTN
269
Palatin Technologies
PTN
$13.7M
$5K ﹤0.01%
9
-6
-40% -$3.13K
AMPE
270
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$4K ﹤0.01%
33
BIIB icon
271
Biogen
BIIB
$30B
-866
Closed -$207K
CGBD icon
272
Carlyle Secured Lending
CGBD
$694M
-14,100
Closed -$193K
CHTR icon
273
Charter Communications
CHTR
$17.3B
-315
Closed -$205K
DIOD icon
274
Diodes
DIOD
$3.78B
-1,900
Closed -$208K
GFF icon
275
Griffon
GFF
$3.95B
-7,160
Closed -$203K

Similar funds

WealthTrust Axiom's Q1 2022 Portfolio in Review

As of Q1 2022, WealthTrust Axiom held 284 positions worth $320M, up 2.3% from $313M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

WealthTrust Axiom's Q1 2022 filing shows 14 new, 76 increased, 75 reduced and 14 closed positions. Its largest new stake was Agnico Eagle Mines: 27,225 shares worth $1.67M. The largest sale was Nutrien, an estimated $2.21M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • WealthTrust Axiom's largest Q1 2022 buy was Agnico Eagle Mines: 27,225 shares worth $1.67M.
  • WealthTrust Axiom added most to AB InBev in Q1 2022, an estimated $1.03M increase.
  • WealthTrust Axiom's biggest Q1 2022 reduction was Nutrien, cutting an estimated $2.21M.
  • WealthTrust Axiom fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $1.4M.
  • WealthTrust Axiom's ten largest holdings make up 29% of its $320M portfolio in Q1 2022.
  • WealthTrust Axiom opened 14 new positions and closed 14 in Q1 2022.
  • WealthTrust Axiom's portfolio value rose 2.3% quarter-over-quarter to $320M.

Based on WealthTrust Axiom's 13F filing for Q1 2022, filed 9 May 2022.